1-9 of 9
Dirk Geerts
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 235: Differential polyamine expression in human pancreatic cancer supports the use of polyamine blockade therapy to modulate the in vivo pancreatic tumor microenvironment

Free
Sai Preethi Nakkina, Sarah B. Gitto, Veethika Pandey, Jignesh Parikh, Dirk Geerts, Carlo Maurer, Kenneth P. Olive, Otto Phanstiel, Deborah A. Altomare
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 235.
https://doi.org/10.1158/1538-7445.AM2022-235
Published: 15 June 2022
View articletitled, Abstract 235: Differential polyamine expression in human pancreatic cancer supports the use of polyamine blockade therapy to modulate the in vivo pancreatic tumor microenvironment
Journal Articles

Abstract PO-120: Differential expression of polyamine pathways in human pancreatic tumor progression and effects of polyamine blockade therapy on the in vivo pancreatic tumor microenvironment

Free
Sai Preethi Nakkina, Sarah B. Gitto, Veethika Pandey, Jignesh G. Parikh, Dirk Geerts, Kenneth P. Olive, Otto Phanstiel, Deborah A. Altomare, Carlo Maurer
Journal: Cancer Research
Cancer Res (2021) 81 (22_Supplement): PO-120.
https://doi.org/10.1158/1538-7445.PANCA21-PO-120
Published: 15 November 2021
View articletitled, Abstract PO-120: Differential expression of polyamine pathways in human pancreatic tumor progression and effects of polyamine blockade therapy on the in vivo pancreatic tumor microenvironment
Journal Articles

Abstract 1902: Potential role of DYRK family kinases in harmine-induced apoptosis in neuroblastoma

Free
Katie L. Uhl, Chad R. Schultz, Dirk Geerts, Andre S. Bachmann
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 1902.
https://doi.org/10.1158/1538-7445.AM2018-1902
Published: 01 July 2018
View articletitled, Abstract 1902: Potential role of DYRK family kinases in harmine-induced apoptosis in neuroblastoma
Journal Articles

Tumorigenic and Antiproliferative Properties of the TALE-Transcription Factors MEIS2D and MEIS2A in Neuroblastoma

Available to Purchase
Anja Groß, Catrine Schulz, Jasmine Kolb, Jan Koster, Sibylle Wehner, Sebastian Czaplinski, Abdulghani Khilan, Hermann Rohrer, Patrick N. Harter, Thomas Klingebiel, Julian D. Langer, Dirk Geerts, Dorothea Schulte
Journal: Cancer Research
Cancer Res (2018) 78 (8): 1935–1947.
https://doi.org/10.1158/0008-5472.CAN-17-1860
Published: 12 April 2018
View articletitled, Tumorigenic and Antiproliferative Properties of the TALE-Transcription Factors MEIS2D and MEIS2A in Neuroblastoma
Open the PDF for Tumorigenic and Antiproliferative Properties of the TALE-Transcription Factors MEIS2D and MEIS2A in Neuroblastoma in another window
Includes: Supplementary data
Journal Articles

Abstract 1394: Stable knockdown of osteoprotegerin increases cell proliferation and metastasis in breast cancer cells.

Free
Michael Weichhaus, Prabu Segaran, Andrew Le, Dirk Geerts, Linda Connelly
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 1394.
https://doi.org/10.1158/1538-7445.AM2013-1394
Published: 15 April 2013
View articletitled, Abstract 1394: Stable knockdown of osteoprotegerin increases cell proliferation and metastasis in breast cancer cells.
Journal Articles

Abstract 1364: Osteoprotegerin production by breast cancer cells: Regulation by NF-kappaB and role in metastasis

Free
Michael Weichhaus, Prabu Segaran, Dirk Geerts, Linda Connelly
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 1364.
https://doi.org/10.1158/1538-7445.AM2012-1364
Published: 15 April 2012
View articletitled, Abstract 1364: Osteoprotegerin production by breast cancer cells: Regulation by NF-kappaB and role in metastasis
Journal Articles

Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated RAS Gene

Available to Purchase
Gerben Schaaf, Mohamed Hamdi, Danny Zwijnenburg, Arjan Lakeman, Dirk Geerts, Rogier Versteeg, Marcel Kool
Journal: Cancer Research
Cancer Res (2010) 70 (2): 762–771.
https://doi.org/10.1158/0008-5472.CAN-09-2532
Published: 13 January 2010
View articletitled, Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated RAS Gene
Open the PDF for Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated RAS Gene in another window
Includes: Supplementary data
Journal Articles

Abstract #3208: Ornithine decarboxylase and antizyme 2 are prognostic markers for aggressive neuroblastoma independent of MYCN amplification status

Free
Andre Bachmann, Jan Koster, David Albert, Dana-Lynn Koomoa, David Feith, Anthony Pegg, Richard Volckmann, Huib Caron, Rogier Versteeg, Dirk Geerts
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 3208.
Published: 01 May 2009
View articletitled, Abstract #3208: Ornithine decarboxylase and antizyme 2 are prognostic markers for aggressive neuroblastoma independent of MYCN amplification status
Journal Articles

The MEIS1 homeobox gene is a neuroblastoma oncogene.

Free
Dirk Geerts, Nathalie Schilderink, Gerda Jorritsma, Ingrid Revet, Rogier Versteeg
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 555–556.
Published: 01 April 2004
View articletitled, The MEIS1 homeobox gene is a neuroblastoma oncogene.